Direct-to-consumer prescription drug advertising, 1989-1998: A content analysis of conditions, targets, inducements, and appeals

Journal of Family Practice

Volumn 49, Issue 4, 2000, Pages 329-335

  Bell, Robert A ^a   Kravitz, Richard L ^b   Wilkes, Michael S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advertising; Direct to consumer promotion non MESH ; Prescriptions, drug

Indexed keywords

ABACAVIR; ADAPALENE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALCIPOTRIOL; DERMATOLOGICAL AGENT; DRUG; EMLA; ESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FINASTERIDE; GANCICLOVIR; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE PLUS ZIDOVUDINE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; METRONIDAZOLE; MICONAZOLE; MINOXIDIL; NELFINAVIR; NEVIRAPINE; PENCICLOVIR; RECOMBINANT ERYTHROPOIETIN; RETINOIC ACID; RITONAVIR; SAQUINAVIR; STAVUDINE; TERBINAFINE; UNINDEXED DRUG;

ARTICLE; CONSUMER; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; FINANCE; LITERATURE; MASS MEDIUM; PRESCRIPTION; PUBLICATION;

ADVERTISING; DRUG INDUSTRY; HUMANS; PERIODICALS; UNITED STATES;

EID: 0033926707     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hollon MF. Direct-to-consumer marketing of prescription drugs: creating consumer demand. JAMA 1999; 281:382-4.
2. Burton TM, Ono Y. Campaign for Prozac targets consumers. Wall Street Journal July 1, 1997:B1, B6.
3. Growth seen in ads for direct-to-consumer drugs. AMA News April 27, 1998:16.
4. Drug Amendments of 1962. Pub L No. 87-781, 76 Stat 780 (1962).
5. Kessler DA, Pine WL. The federal regulation of prescription drug advertising and promotion. JAMA 1990; 264:2409-15.
6. Bradley LR, Zito JM. Direct-to-consumer prescription drug advertising. Med Care 1997; 35:86-92.
7. T'Hoen E. Direct-to-consumer advertising: for better profits or for better health? Am J Health Syst Pharm 1998; 55:594-7.
8. Barrett A. Are drug ads a cure-all? Business Week March 30, 1998:59-60.
9. Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA 1999; 281:380-2.
10. Pushing ethical pharmaceuticals direct to the public. Lancet 1998; 351:921.
11. Hoffman JR, Wilkes M. Direct to consumer advertising of prescription drugs. BM J 1999; 318:1301-2.
12. Ingram RA. Some comments on direct-to-consumer advertising. J Pharm Marketing Manage 1992; 7:67-74.
13. Masson A, Rubin PH. Matching prescription drugs and consumers. N Engl J Med 1985; 313:513-5.
14. Keith A. The benefits of pharmaceutical promotion: an economic and health perspective. J Pharm Marketing Manage 1992; 7:121-33.
15. Lober CW. Ethics in pharmaceutical advertising. Dermatol Clin 1993; 11:285-8.
16. Bell RA, Wilkes MS, Kratvitz RL. Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. J Fam Pract 1999; 48:446-52.
17. Committee on Drugs. Prescription drug advertising direct to the consumer. Pediatrics 1991; 88:174-5.
18. Bernstein A. Prescription drugs: pitching directly to the patient. US News & World Report 1990; 108:46-7.
19. Katz WA. Magazines for libraries New Providence, NJ: R. R. Bowker; 1997.
20. SPSS. SPSS 9.0 regression models. Chicago, Ill: SPSS; 1999.
21. Wind Y. Pharmaceutical advertising: a business school perspective. Arch Fam Med 1994; 3:321-3.
22. Levy R. The role and value of pharmaceutical marketing. Arch Fam Med 1994; 3:327-32.
23. Kessler DA, Rose JL, Temple RJ, Schapiro R, Griffin JP. Therapeutic-class wars: drug promotion in a competitive marketplace. N Engl J Med 1994; 331:1350-3.
24. Ferner RE, Scott DK. Whatalotwegot: the messages in drug advertisements. BMJ 1994; 309:1734-8.